{"slug":"sk-biopharmaceuticals","name":"SK바이오팜","name_en":"SK Biopharmaceuticals","ticker":"326030.KS","updated_at":"2026-07-11T10:22:29.832+00:00","canonical":"https://valuechain.wiki/sk-biopharmaceuticals","kicker":"코스피 대형주","kicker_en":"KOSPI large cap","lead":"중추신경계 신약을 개발하는 제약기업으로, 자체 개발한 뇌전증 치료제 세노바메이트를 미국에서 직접 판매한다. 코스피 시가총액 상위 종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A pharma company developing central-nervous-system drugs, directly selling its self-developed epilepsy drug cenobamate in the U.S. KOSPI large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"뇌전증 치료제(세노바메이트)"},{"name":"로열티/기타"}]},"segments_en":{"parts":[{"name":"Epilepsy drug (cenobamate)"},{"name":"Royalties/others"}]},"returns_yearly":{"2021":-47.7,"2022":-4.4,"2023":28.3,"2024":17.3,"2025":8.2,"2026":-30.2},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}